Table 3 Variables associated with amygdala levels of phospho-GluA1-Ser831
Variables | Amygdala levels of phospho-GluA1-Ser831 | P-value | ||
---|---|---|---|---|
Univariate analysis a | ||||
Gender | Mean (s.e.) | |||
Female | 103 (3.6) | |||
Male | 117.4 (4.5) | 0.02a | ||
AEDs regimen | ||||
Monotherapy | 114 (5.0) | |||
Two AEDs or more | 109 (3.9) | 0.51a | ||
Phenobarbital treatment | ||||
No | 111.7 (3.8) | |||
Yes | 105.4 (4.9) | 0.32a | ||
B | r | r2 | P-value | |
Univariate linear regressions | ||||
Monthly seizure frequency | −0.71 | 0.21 | 0.05 | 0.26b |
Serum glucose | −0.19 | 0.32 | 0.10 | 0.12b |
Storage time of samples (months) | 0.36 | 0.19 | 0.04 | 0.30b |
Dexamethasone dose (mg kg−1) | −145.6 | 0.69 | 0.48 | 0.00002b |
Multiple linear regression | ||||
Constant | 134.8 | <0.00001 | ||
Female | −0.90 | 0.85 | ||
Serum glucose | −0.10 | 0.33 | ||
Dexamethasone dose (mg kg−1) | −131.1 | 0.0003 | ||
0.73 | 0.53 | 0.001c |